Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allisartan isoproxil and sexual function in mild to moderate hypertension
ChiCTR2500106035Phase 4Completed
- Sponsor
- Second Hospital of Lanzhou University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of allisartan isoproxil in hypertension (HTN) and erectile dysfunction (ED) (2 arms), sponsored by Second Hospital of Lanzhou University. Primary endpoints: Sexual function score and Blood pressure. Started Jul 2025; status: completed.
02
Drugs
allisartan isoproxil
03
Conditions
hypertension (HTN)erectile dysfunction (ED)
Beyond the preview
Go deeper on ChiCTR2500106035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106035.